Advertisement

Possible Factors Contributing to Persistence of Cytomegalovirus Infection

  • R. V. Blanden
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 257)

Abstract

The purpose of this article is to discuss factors which may contribute to the persistance of cytomegalovirus (CMV) infection in the face of host responses. In general, available evidence suggests that cell-mediated rather than humoral immunity is important for the control of CMV infection. For example, immunosuppressed humans die of progressive HCMV infection in the presence of normal or high antibody levels (Rasmussen et al., 1982). Furthermore T cell deficient mice are more susceptible to MCMV infection than normal controls (Grundy and Melief, 1982) and transferred T cells confer protection (Grundy and Melief, 1982; Starr and Allison, 1977; Ho, 1980; Reddehase et al., 1985). Therefore I intend to focus on factors which may influence the expression and effectiveness of cell-mediated mechanisms against CMV infection.

Keywords

Natural Killer Cell Gamma Interferon Recombinant Vaccinia Virus MCMV Infection Cell Deficient Mouse 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andrew, M.E., Coupar, B.E.H., Boyle, D.B. and Blanden, R.V., 1987, Eur J. Immunol. 17:1515.PubMedCrossRefGoogle Scholar
  2. Bancroft, G.J., Shellam, G.R. and Chalmer, J.E., 1981, J. Immunol. 126:988.PubMedGoogle Scholar
  3. Beck, S. and Barrell, B.G., 1988, Nature 331:269. Bjorkman, P.J., Saper, M.A., Samraoui, B., Bennett, W.S., Strominger, J.L. and Wiley, D.C., 1987a, Nature 329:506.PubMedCrossRefGoogle Scholar
  4. Bjorkman, P.J., Saper, M.A., Samraoui, B., Bennett, W.S., Strominger, J.L. and Wiley, D.C., 1987a, Nature 329:506PubMedCrossRefGoogle Scholar
  5. Bjorkman, P.J., Saper, M.A., Samraoui, B., Bennett, W.S., Strominger, J.L. and Wiley, D.C., 1987b, Nature 329:512.PubMedCrossRefGoogle Scholar
  6. Blanden, R.V., 1971, J. Exp. Med. 133:1090.PubMedCrossRefGoogle Scholar
  7. Blanden, R.V., 1974, Transplant. Rev. 19:56.PubMedGoogle Scholar
  8. Blanden, R.V., Hodgkin, P.D., Hill, A., Sinickas, V.G. and Müllbacher, A., 1987, Immunol. Rev. 98:75.PubMedCrossRefGoogle Scholar
  9. Coupar, B.E.H., Andrew, M.E., Both, G.W. and Boyle, D.B., 1986, Eur. J. Immunol. 16:1479.PubMedCrossRefGoogle Scholar
  10. Gardner, I.D., Bowern, N.A. and Blanden, R.V., 1975, Eur. J. Immunol. 5:122.PubMedCrossRefGoogle Scholar
  11. Goldstein, S.A.N. and Mescher, M., 1987, J. Immunol. 138:2034.PubMedGoogle Scholar
  12. Grundy (Chalmer), J.E. and Melief, C.J.M., 1982, J. Gen. Virol. 61:133.PubMedCrossRefGoogle Scholar
  13. Grundy (Chalmer), J.E., Mackenzie, J.S. and Stanley, N.F., 1981, Infect, and Immun. 32:277.Google Scholar
  14. Grundy, J.E., McKeating, J.A. and Griffiths, P.D., 1987, J. Gen Virol. 68:777.PubMedCrossRefGoogle Scholar
  15. Ho, M. , 1980, Infect. Immun. 27:767.PubMedGoogle Scholar
  16. Ho, M. and Ashman, R.B. , 1979, Aust. J. Exp. Biol. and Med. Sci. 57:425.CrossRefGoogle Scholar
  17. McKeating, J.A., Griffiths, P.D. and Grundy, J.E., 1987, J. Gen. Virol. 68:785.PubMedCrossRefGoogle Scholar
  18. Müllbacher, A. and King, N.J.C., 1989, Scand. J. Immunol., in press.Google Scholar
  19. O’Neill, H.C. and Blanden, R.V., 1979, J. Exp. Med. 149:724.PubMedCrossRefGoogle Scholar
  20. Pointek, G.E., Taniguchi, K., Ljunggren, H., Gronberg, A., Kiessling, R. , Klein, G. and Karre, K., 1985, J. Immunol. 135:4281.Google Scholar
  21. Quinnan, G.V. and Manischewitz, J.E., 1979, J. Exp. Med. 150:1549.PubMedCrossRefGoogle Scholar
  22. Quinnan, G.V., Manischewitz, J.E. and Ennis, F.A., 1978, Nature 273:541.PubMedCrossRefGoogle Scholar
  23. Quinnan, G.V., Manischewitz, J.E. and Ennis, F.A., 1980, J. Gen. Virol. 47:503.PubMedCrossRefGoogle Scholar
  24. Rasmussen, L., Kelsall, D., Nelson, R., Carray, W., Hirsch, M., Winston, D., Preikaitis, J. and Merigan, T., 1982, J. Infect. Dis. 145:191.PubMedCrossRefGoogle Scholar
  25. Reddehase, M.J., Weiland, F., Munch, K., Jonjic, S., Luske, A. and Koszinowski, U.H., 1985, J. Virol. 55:264.PubMedGoogle Scholar
  26. Reddehase, M.J. and Koszinowski, U.H., 1984, Nature 312:369.PubMedCrossRefGoogle Scholar
  27. Sethi, K.K. and Brandis, H., 1979, Arch. Virol. 60:227PubMedCrossRefGoogle Scholar
  28. Shimonkevitz, R., Luescher, B., Cerottini, J.-C. and MacDonald, H.R., 1985, J. Immunol. 135:892.PubMedGoogle Scholar
  29. Sinickas, V.G., Ashman, R.B. and Blanden, R.V., 1985, J. Gen. Virol. 66:747.PubMedCrossRefGoogle Scholar
  30. Sinickas, V.G., Ashman, R.B. and Blanden, R.V., 1987, Immunol, and Cell Biol. 65:173.CrossRefGoogle Scholar
  31. Sissons, J.G.P., Borysiewicz, L.K., Rodgers, B. and Scott, D., 1986, Immunology Today 7:57.CrossRefGoogle Scholar
  32. Solheim, B.G. and Thorsby, E., 1974, Tissue Antigens, 4:83.PubMedCrossRefGoogle Scholar
  33. Starr, S.E. and Allison, A.C., 1977, Infect. Immun. 17:458.PubMedGoogle Scholar
  34. Storkus, W.J., Howell, D.N., Salter, R.D., Dawson, J.R. and Cresswell, P., 1987, J. Immunol. 138:1657.PubMedGoogle Scholar
  35. Stroynowski, I., Soloski, M., Lowe, M.G. and Hood, L., 1987, Cell 50:759.PubMedCrossRefGoogle Scholar
  36. Townsend, A.R.M., Rothbard, J., Gotch, F.M., Bahadur, G., Wraith, D. and McMichael, A.J., 1986a, Cell 44:959.PubMedCrossRefGoogle Scholar
  37. Townsend, A.R.M., Bastin, J., Gould, K. and Brownley, G.G., 1986b, Nature 324:575.PubMedCrossRefGoogle Scholar
  38. Wiley, D., 1988, Nature 331:209.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • R. V. Blanden
    • 1
  1. 1.Division of Cell Biology John Curtin School of Medical ResearchAustralian National UniversityCanberra CityAustralia

Personalised recommendations